ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,585.59
(
0.8%
)
US Tech 100
15,617.20
(
0.0%
)
Dow Jones
36,117.38
(
0.17%
)
Brent Oil
75.76
(
1.51%
)
Bitcoin
43,265.18
(
-0.08%
)
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Panbela Therapeutics Inc (PBLA)

  7. Panbela Therapeutics Inc (PBLA) News

PBLA Panbela Therapeutics Inc

0.4883
0.00 (0.0%)
Dec 07 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Panbela Therapeutics Inc PBLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 0.4883 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.4883
more quote information »

Recent News

Date Time Source Heading
12/04/202308:00GLOBEPanbela Announces Publication of Abstract Titled: Evaluation..
12/01/202316:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/01/202316:15EDGAR2Form 8-K - Current report
11/29/202308:15GLOBEPanbela Announces 2nd Independent Safety Review of the..
11/24/202316:30EDGAR2Form DEF 14A - Other definitive proxy statements
11/22/202317:01EDGAR2Form S-1 - General form for registration of securities under..
11/17/202317:10EDGAR2Form D - Notice of Exempt Offering of Securities
11/09/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:10EDGAR2Form 8-K - Current report
11/09/202316:10GLOBEPanbela Provides Business Update and Reports Q3 2023..
11/03/202317:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/03/202317:24EDGAR2Form 8-K - Current report
11/03/202307:55GLOBEPanbela Therapeutics Announces Exercise of Warrants and..
11/02/202308:15GLOBEPanbela Announces Publication of Preclinical and Clinical..
10/31/202308:15GLOBEPanbela Announces Validation of European Patent in UK,..
10/25/202308:15GLOBEAcceptance of Polyamine Inhibitor CAR-T Combination Abstract..
10/24/202308:15GLOBEPanbela to Host Third Quarter 2023 Earnings Conference Call..
9/26/202308:15GLOBEPanbela Announces Issuance of New Patent in China for Claims..
9/19/202308:15GLOBEPanbela to Present at the LD Micro Investor Conference
9/14/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202308:15GLOBEPanbela Announces Issuance of New Patent in Chile for Claims..
8/28/202308:15GLOBEPanbela to Present at H.C. Wainwright 25th Annual Global..
8/14/202308:15GLOBEPanbela Announces Issuance of New Patent in Europe for..
8/10/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:11EDGAR2Form 8-K - Current report
8/10/202316:10GLOBEPanbela Provides Business Update and Reports Q2 2023..
7/31/202316:15GLOBEPanbela to Host Second Quarter 2023 Earnings Conference Call..
7/24/202308:15GLOBEPanbela Opens Enrollment in UK and Germany for Aspire Trial..
7/19/202308:02EDGAR2Form 8-K - Current report
7/19/202308:00GLOBEPanbela Therapeutics to Receive a Total Up to $9.5 Million..
7/17/202306:00GLOBEPanbela Announces Issuance of New Patent in Australia Patent..
7/10/202316:15EDGAR2Form 8-K - Current report
7/10/202308:15GLOBEPanbela Announces Preliminary Safety Analysis for ASPIRE..
6/28/202308:15GLOBEPanbela Announces PACES S0820 Phase III Trial Passes..
6/26/202308:15GLOBEPanbela Announces Poster Presentation at the Endocrine..
6/21/202316:15GLOBEPanbela Announces Closing of Approximately $8.5 Million..
6/16/202308:15GLOBEPanbela Announces Pricing of Approximately $8.5 Million..
6/13/202308:15GLOBEPanbela Announces Sponsored Research Agreement to Evaluate..
6/01/202308:15GLOBEPanbela Announces Poster Presentation at Immunology of..
5/31/202308:00GLOBEPanbela Announces 1-for-30 Reverse Stock Split Effective..
5/22/202308:15GLOBEPanbela Announces Clinical Trial with Moffitt Cancer Center..
5/04/202316:10GLOBEPanbela Provides Business Update and Reports Q1 2023..
4/24/202308:15GLOBEPanbela to Host First Quarter 2023 Earnings Conference Call..
4/19/202308:15GLOBEPanbela Announces Poster Presentation at American..
4/12/202308:15GLOBEFirst Patient Enrolled in JDRF-Funded Phase II Trial of..
4/11/202308:15GLOBEPanbela Regains Worldwide Rights to Develop and..
4/10/202308:30GLOBEAcceptance of CPP-1X (DFMO) Abstract for Poster Presentation..
4/06/202308:30GLOBEAcceptance of CPP-1X (DFMO) Abstract for Poster Presentation..
4/03/202308:30GLOBEPanbela Announces New Research Agreement with Johns Hopkins..
3/22/202308:30GLOBEPanbela Announces Issuance of New Patent in Japan; Patent is..

Your Recent History

NASDAQ
PBLA
Panbela Therapeutics
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com